Citius Oncology, Inc. CTOR Purchase Obligation
Purchase Obligation at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted.
The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s purchase obligation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Citius Oncology, Inc.'s purchase obligation?
- Citius Oncology, Inc. (CTOR) reported purchase obligation of $16.2M in Q3 2025.
- What does purchase obligation mean?
- This represents legally binding commitments to purchase goods or services from third parties in future periods. It provides insight into the company's future cash outflow requirements and operational dependencies. Monitoring these obligations is essential for assessing the company's liquidity position and its ability to meet contractual commitments.